Reporting of Late-Onset Immune-Related Adverse Events with Immune Checkpoint Inhibitors in VigiBase

Scientists identified drug- and patient-related characteristics potentially associated with the reporting of late-onset immune-related adverse events with immune checkpoint inhibitors in VigiBase, the WHO global database of individual case safety reports.